Literature DB >> 14585304

Homologous metabolic and gene activating routes for vitamins E and K.

Nico Landes1, Marc Birringer, Regina Brigelius-Flohé.   

Abstract

Vitamins E and K share structurally related side chains and are degraded to similar final products. For vitamin E the mechanism has been elucidated as initial omega-hydroxylation and subsequent beta-oxidation. For vitamin K the same mechanism can be suggested analogously. omega-Hydroxylation of vitamin E is catalyzed by cytochrome p450 enzymes, which often are induced by their substrates themselves via the activation of the nuclear receptor PXR. Vitamin E is able to induce CYP3A-forms and to activate a PXR-driven reporter gene. It is shown here that K-type vitamins are also able to activate PXR. A ranking showed that compounds with an unsaturated side chain were most effective, as are tocotrienols and menaquinone-4 (vitamin K(2)), which activated the reporter gene 8-10-fold. Vitamers with a saturated side chain, like tocopherols and phylloquinone were less active (2-5-fold activation). From the fact that CYPs commonly responsible for the elimination of xenobiotics are involved in the metabolism of fat-soluble vitamins and the ability of the vitamins to activate PXR it can be concluded that supranutritional amounts of these vitamins might be considered as foreign.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14585304     DOI: 10.1016/s0098-2997(03)00029-3

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  12 in total

1.  A new LC-MS assay for the quantitative analysis of vitamin K metabolites in human urine.

Authors:  Matthew G McDonald; Catherine K Yeung; Aaron M Teitelbaum; Amanda L Johnson; Shinya Fujii; Hiroyuki Kagechika; Allan E Rettie
Journal:  J Lipid Res       Date:  2019-01-22       Impact factor: 5.922

Review 2.  Complexity of vitamin E metabolism.

Authors:  Lisa Schmölz; Marc Birringer; Stefan Lorkowski; Maria Wallert
Journal:  World J Biol Chem       Date:  2016-02-26

3.  The bladder tumor suppressor protein TERE1 (UBIAD1) modulates cell cholesterol: implications for tumor progression.

Authors:  William J Fredericks; Terry McGarvey; Huiyi Wang; Priti Lal; Raghunath Puthiyaveettil; John Tomaszewski; Jorge Sepulveda; Ed Labelle; Jayne S Weiss; Michael L Nickerson; Howard S Kruth; Wolfgang Brandt; Ludger A Wessjohann; S Bruce Malkowicz
Journal:  DNA Cell Biol       Date:  2011-07-08       Impact factor: 3.311

4.  CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant.

Authors:  Matthew G McDonald; Mark J Rieder; Mariko Nakano; Clara K Hsia; Allan E Rettie
Journal:  Mol Pharmacol       Date:  2009-03-18       Impact factor: 4.436

5.  Regulation of murine hepatic hydroxysteroid sulfotransferase expression in hyposulfatemic mice and in a cell model of 3'-phosphoadenosine-5'-phosphosulfate deficiency.

Authors:  Kathleen G Barrett; Hailin Fang; Mary D Gargano; Daniel Markovich; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Drug Metab Dispos       Date:  2013-05-14       Impact factor: 3.922

Review 6.  The pregnane X receptor: from bench to bedside.

Authors:  Xiaochao Ma; Jeffrey R Idle; Frank J Gonzalez
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-07       Impact factor: 4.481

7.  The skin function: a factor of anti-metabolic syndrome.

Authors:  Shi-Sheng Zhou; Da Li; Yi-Ming Zhou; Ji-Min Cao
Journal:  Diabetol Metab Syndr       Date:  2012-04-26       Impact factor: 3.320

8.  Extrahepatic tissue concentrations of vitamin K are lower in rats fed a high vitamin E diet.

Authors:  Alison Tovar; Clement K Ameho; Jeffrey B Blumberg; James W Peterson; Donald Smith; Sarah L Booth
Journal:  Nutr Metab (Lond)       Date:  2006-07-20       Impact factor: 4.169

Review 9.  Lipophilic micronutrients and adipose tissue biology.

Authors:  Jean-François Landrier; Julie Marcotorchino; Franck Tourniaire
Journal:  Nutrients       Date:  2012-11-06       Impact factor: 5.717

10.  The tumor suppressor TERE1 (UBIAD1) prenyltransferase regulates the elevated cholesterol phenotype in castration resistant prostate cancer by controlling a program of ligand dependent SXR target genes.

Authors:  William J Fredericks; Jorge Sepulveda; Priti Lai; John E Tomaszewski; Ming-Fong Lin; Terry McGarvey; Frank J Rauscher; S Bruce Malkowicz
Journal:  Oncotarget       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.